Morgan Stanley’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.4M Buy
1,060,500
+136,125
+15% +$12.2M 0.01% 1522
2025
Q4
$80.7M Buy
924,375
+83,371
+10% +$6.33M ﹤0.01% 1637
2025
Q3
$48.2M Sell
841,004
-30,607
-4% -$1.76M ﹤0.01% 2041
2025
Q2
$51.4M Buy
871,611
+188,510
+28% +$12.2M ﹤0.01% 1909
2025
Q1
$50M Sell
683,101
-63,060
-8% -$5.21M ﹤0.01% 1816
2024
Q4
$61.7M Buy
746,161
+158,674
+27% +$12.5M ﹤0.01% 1638
2024
Q3
$42M Sell
587,487
-93,277
-14% -$6.58M ﹤0.01% 1999
2024
Q2
$46.6M Sell
680,764
-35,220
-5% -$2.1M ﹤0.01% 1828
2024
Q1
$38.4M Sell
715,984
-666,678
-48% -$35.8M ﹤0.01% 2011
2023
Q4
$73.7M Buy
1,382,662
+728,579
+111% +$35.5M ﹤0.01% 2036
2023
Q3
$32.5M Buy
654,083
+15,504
+2% +$867K ﹤0.01% 1975
2023
Q2
$38M Sell
638,579
-3,800
-0.6% -$217K ﹤0.01% 1847
2023
Q1
$36.4M Sell
642,379
-443,910
-41% -$28.5M ﹤0.01% 1843
2022
Q4
$80.7M Sell
1,086,289
-123,962
-10% -$8.44M 0.01% 1173
2022
Q3
$72.1M Sell
1,210,251
-127,788
-10% -$7.7M 0.01% 1079
2022
Q2
$75.1M Buy
1,338,039
+335,692
+33% +$22.1M 0.01% 1100
2022
Q1
$74M Buy
1,002,347
+850,086
+558% +$59.1M 0.01% 1053
2021
Q4
$11M Sell
152,261
-157,876
-51% -$11.5M ﹤0.01% 2849
2021
Q3
$23.8M Buy
310,137
+102,448
+49% +$8.23M ﹤0.01% 1908
2021
Q2
$16.1M Buy
207,689
+10,577
+5% +$752K ﹤0.01% 2402
2021
Q1
$12.2M Sell
197,112
-42,989
-18% -$2.72M ﹤0.01% 2445
2020
Q4
$15.7M Sell
240,101
-80,186
-25% -$4.61M ﹤0.01% 2051
2020
Q3
$15.9M Buy
320,287
+120,895
+61% +$6.24M ﹤0.01% 1650
2020
Q2
$9.51M Buy
199,392
+144,675
+264% +$6.98M ﹤0.01% 2018
2020
Q1
$2.33M Sell
54,717
-141,889
-72% -$7.01M ﹤0.01% 3230
2019
Q4
$11.6M Buy
196,606
+134,160
+215% +$7.28M ﹤0.01% 2259
2019
Q3
$3.19M Sell
62,446
-23,974
-28% -$1.14M ﹤0.01% 3354
2019
Q2
$3.65M Buy
86,420
+22,625
+35% +$982K ﹤0.01% 3246
2019
Q1
$3.15M Sell
63,795
-616,830
-91% -$27.9M ﹤0.01% 3163
2018
Q4
$29.5M Buy
680,625
+202,569
+42% +$10.1M 0.01% 1139
2018
Q3
$27.1M Sell
478,056
-48,895
-9% -$2.57M 0.01% 1408
2018
Q2
$26.6M Buy
526,951
+170,673
+48% +$8.9M 0.01% 1381
2018
Q1
$17.8M Buy
356,278
+27,537
+8% +$1.29M ﹤0.01% 1780
2017
Q4
$13.5M Buy
328,741
+13,622
+4% +$477K ﹤0.01% 2083
2017
Q3
$9.37M Buy
315,119
+109,458
+53% +$3.34M ﹤0.01% 2346
2017
Q2
$6.82M Sell
205,661
-116,520
-36% -$3.66M ﹤0.01% 2536
2017
Q1
$9.54M Sell
322,181
-49,348
-13% -$1.35M ﹤0.01% 2240
2016
Q4
$9.22M Buy
371,529
+146,048
+65% +$3.32M ﹤0.01% 2338
2016
Q3
$5.09M Sell
225,481
-42,921
-16% -$1.01M ﹤0.01% 2639
2016
Q2
$6.4M Sell
268,402
-207,588
-44% -$4.98M ﹤0.01% 2382
2016
Q1
$11.3M Buy
475,990
+400,465
+530% +$9.79M ﹤0.01% 1763
2015
Q4
$2.1M Buy
75,525
+21,202
+39% +$532K ﹤0.01% 3449
2015
Q3
$1.12M Sell
54,323
-61,227
-53% -$1.55M ﹤0.01% 4014
2015
Q2
$2.97M Buy
115,550
+56,217
+95% +$1.42M ﹤0.01% 3254
2015
Q1
$1.5M Sell
59,333
-119,167
-67% -$2.9M ﹤0.01% 3819
2014
Q4
$4.24M Sell
178,500
-172,315
-49% -$3.82M ﹤0.01% 2882
2014
Q3
$6.9M Sell
350,815
-29,444
-8% -$606K ﹤0.01% 2342
2014
Q2
$9.1M Buy
380,259
+140,458
+59% +$3.39M ﹤0.01% 2117
2014
Q1
$6.38M Buy
239,801
+147,854
+161% +$3.51M ﹤0.01% 2351
2013
Q4
$1.85M Buy
91,947
+34,990
+61% +$650K ﹤0.01% 3433
2013
Q3
$995K Buy
56,957
+12,247
+27% +$212K ﹤0.01% 3792
2013
Q2
$754K Buy
+44,710
New +$690K ﹤0.01% 3948

Other funds holding GMED